Cargando…

Development of a SPE-LC-MS Method for the Quantitation of Palbociclib and Abemaciclib in Human Plasma

Palbociclib and abemaciclib are two cyclin-dependent kinases 4 and 6 used for breast cancer treatment. Levels of these medicines present a significant interindividual variability, so monitoring those concentrations might be necessary in therapy. Most of the methods presented so far in the literature...

Descripción completa

Detalles Bibliográficos
Autores principales:	Calucică, Daniela Maria, Manda, Costel-Valentin, Găman, Amelia Maria, Răileanu, Ștefan, Stanca, Liliana, Popescu, Monica Denisa Elena, Mateescu, Olivia Garofița, Biță, Andrei, Croitoru, Octavian, Neamțu, Simona-Daniela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9736392/ https://www.ncbi.nlm.nih.gov/pubmed/36500697 http://dx.doi.org/10.3390/molecules27238604

Ejemplares similares

Simultaneous Determination of Two Tyrosine Kinase Inhibitors in Tablets by HPLC-MS analysis
por: CROITORU, DANIELA MARIA, et al.
Publicado: (2022)

Uncommon etiologies of infectious tonsillitis in adults
por: Bold, Adriana, et al.
Publicado: (2013)

Differences in metabolic transport and resistance mechanisms of Abemaciclib, Palbociclib, and Ribociclib
por: Zhu, Zhimin, et al.
Publicado: (2023)

Evaluation of potential complication of interstitial lung disease with abemaciclib and palbociclib treatments
por: Nawa, Hideki, et al.
Publicado: (2021)

The procoagulant status. Hypercoagulability as a risk factor of primary and secondary infertility
por: Neamţu, Simona-Daniela, et al.
Publicado: (2021)

Fetal–maternal incompatibility in the Rh system. Rh isoimmunization associated with hereditary spherocytosis: case presentation and review of the literature
por: Neamţu, Simona-Daniela, et al.
Publicado: (2022)

Inhibiting CDK4/6 in Breast Cancer with Palbociclib, Ribociclib, and Abemaciclib: Similarities and Differences
por: Braal, C. Louwrens, et al.
Publicado: (2020)

Letter to the Editor: statistics and clinical perception of patients’ reported outcomes for palbociclib and abemaciclib: a sliding doors story
por: Gebbia, Vittorio, et al.
Publicado: (2023)

Biological Effects of Cyclin-Dependent Kinase Inhibitors Ribociclib, Palbociclib and Abemaciclib on Breast Cancer Bone Microenvironment
por: Iuliani, Michele, et al.
Publicado: (2022)

Analysis of Amisulpride in Human Plasma by SPE and LC with Fluorescence Detection
por: Kudris, Illia V., et al.
Publicado: (2011)

Rapid Capillary Electrophoresis Method for Simultaneous Determination of Abemaciclib, Ribociclib, and Palbociclib in Pharmaceutical Dosage Forms: A Green Approach
por: Mlinarić, Zvonimir, et al.
Publicado: (2022)

Development and Validation of a Novel LC-MS/MS Method for the Simultaneous Determination of Abemaciclib, Palbociclib, Ribociclib, Anastrozole, Letrozole, and Fulvestrant in Plasma Samples: A Prerequisite for Personalized Breast Cancer Treatment
por: Turković, Lu, et al.
Publicado: (2022)

Response to Abemaciclib After 10 Lines of Therapy Including Palbociclib in Metastatic Breast Cancer: A Case Report With Literature Review
por: Wender, Isabella O., et al.
Publicado: (2020)

Combination of Abemaciclib following Eribulin Overcomes Palbociclib-Resistant Breast Cancer by Inhibiting the G2/M Cell Cycle Phase
por: Pandey, Kamal, et al.
Publicado: (2022)

Economic Evaluation for Palbociclib Plus Fulvestrant vs Ribociclib Plus Fulvestrant and Abemaciclib Plus Fulvestrant in Endocrine-Resistant Advanced or Metastatic Breast Cancer in Italy
por: Colombo, Giorgio Lorenzo, et al.
Publicado: (2023)

Screen-Printed Electrodes (SPE) for In Vitro Diagnostic Purpose
por: Mincu, Nicolae-Bogdan, et al.
Publicado: (2020)

Letter in Reply: indirect comparison of quality-of-life scores between patients with advanced breast cancer receiving palbociclib and abemaciclib in combination with fulvestrant
por: Law, Ernest H, et al.
Publicado: (2023)

Abemaciclib, Palbociclib, and Ribociclib in Real-World Data: A Direct Comparison of First-Line Treatment for Endocrine-Receptor-Positive Metastatic Breast Cancer
por: Cejuela, Mónica, et al.
Publicado: (2023)

Determination of Organophosphate Ester Metabolites in Seafood Species by QuEChERS-SPE Followed by LC-HRMS
por: Hidalgo-Serrano, Míriam, et al.
Publicado: (2022)

Abemaciclib for breast cancer
Publicado: (2020)

The role of abemaciclib in treatment of advanced breast cancer
por: McCartney, Amelia, et al.
Publicado: (2018)

The Clinical Profile of Cat-Scratch Disease’s Neuro-Ophthalmological Effects
por: Jurja, Sanda, et al.
Publicado: (2022)

Investigation on acquired palbociclib resistance by LC-MS based multi-omics analysis
por: Xue, Zhichao, et al.
Publicado: (2023)

Off-Line SPE LC-LRMS Polyphenolic Fingerprinting and Chemometrics to Classify and Authenticate Spanish Honey
por: García-Seval, Víctor, et al.
Publicado: (2022)

Assessment of Tryptophan, Tryptophan Ethylester, and Melatonin Derivatives in Red Wine by SPE-HPLC-FL and SPE-HPLC-MS Methods
por: Fracassetti, Daniela, et al.
Publicado: (2019)

Development and Validation of an HPLC Method for Simultaneous Quantification of Clopidogrel Bisulfate, Its Carboxylic Acid Metabolite, and Atorvastatin in Human Plasma: Application to a Pharmacokinetic Study
por: Croitoru, Octavian, et al.
Publicado: (2015)

Identification of reactive intermediate formation and bioactivation pathways in Abemaciclib metabolism by LC–MS/MS: in vitro metabolic investigation
por: Kadi, Adnan A., et al.
Publicado: (2019)

Extraction and Determination of Vitamin K(1) in Foods by Ultrasound-Assisted Extraction, SPE, and LC-MS/MS
por: Xu, Yueqing, et al.
Publicado: (2020)

Rapid SPE – LC MS/MS analysis for atrazine, its by-products, simazine and S metolachlor in groundwater samples
por: Blanchoud, Hélène, et al.
Publicado: (2020)

Formulation and Characterization of Ciprofloxacin loaded PLGA Microspheres for Applications in Orthopedic Infections
por: MOCANU, ANDREEA-GABRIELA, et al.
Publicado: (2017)

Reusability of SPE and Sb-modified SPE Sensors for Trace Pb(II) Determination
por: Finšgar, Matjaž, et al.
Publicado: (2018)

Development and validation of a bioanalytical method for the quantification of the CDK4/6 inhibitors abemaciclib, palbociclib, and ribociclib in human and mouse matrices using liquid chromatography-tandem mass spectrometry
por: Martínez-Chávez, Alejandra, et al.
Publicado: (2019)

Decreased sensitivity of cyclin-dependent kinase 4/6 inhibitors, palbociclib and abemaciclib to canine lymphoma cells with high p16 protein expression and low retinoblastoma protein phosphorylation
por: MAYLINA, Leni, et al.
Publicado: (2022)

Hormone receptor-positive, HER2-negative, metastatic breast cancer responded well to abemaciclib and exemestane after palbociclib and fulvestrant failure: A case report and literature review
por: Mao, Yan, et al.
Publicado: (2023)

HybridSPE: A novel technique to reduce phospholipid-based matrix effect in LC–ESI-MS Bioanalysis
por: Ahmad, Shafeeque, et al.
Publicado: (2012)

A Fully Automated Online SPE-LC-MS/MS Method for the Determination of 10 Pharmaceuticals in Wastewater Samples
por: Belay, Masho Hilawie, et al.
Publicado: (2022)

LC–MS/MS method for the quantitation of decitabine and venetoclax in rat plasma after SPE: Application to pharmacokinetic study
por: Alnasser, Abdulaziz I., et al.
Publicado: (2023)

Palbociclib in breast cancer neoadjuvant setting
por: Duarte, Sílvia Alexandra Cabral, et al.
Publicado: (2021)

Identification of Alternaria alternata Mycotoxins by LC-SPE-NMR and Their Cytotoxic Effects to Soybean (Glycine max) Cell Suspension Culture
por: de Souza, Gezimar D., et al.
Publicado: (2013)

Rapid Structure Determination of Bioactive 4″-Tetrahydrofurfuryl Macrozone Reaction Mixture Components by LC-SPE/Cryo NMR and MS
por: Habinovec, Iva, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gvpujhk9h0626rmo1oa23qm8hp